- Home
- CEPU vs BLTE Comparison
CEPU vs BLTE Comparison
Compare CEPU & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- BLTE
- Stock Information
- Founded
- CEPU 1989
- BLTE 2018
- Country
- CEPU Argentina
- BLTE United States
- Employees
- CEPU N/A
- BLTE N/A
- Industry
- CEPU Electric Utilities: Central
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- CEPU Utilities
- BLTE Health Care
- Exchange
- CEPU Nasdaq
- BLTE Nasdaq
- Market Cap
- CEPU 1.8B
- BLTE 2.1B
- IPO Year
- CEPU 2018
- BLTE 2022
- Fundamental
- Price
- CEPU $11.51
- BLTE $66.70
- Analyst Decision
- CEPU Hold
- BLTE Strong Buy
- Analyst Count
- CEPU 1
- BLTE 4
- Target Price
- CEPU $12.00
- BLTE $96.67
- AVG Volume (30 Days)
- CEPU 228.0K
- BLTE 53.3K
- Earning Date
- CEPU 03-11-2025
- BLTE 03-17-2025
- Dividend Yield
- CEPU 2.68%
- BLTE N/A
- EPS Growth
- CEPU N/A
- BLTE N/A
- EPS
- CEPU 0.03
- BLTE N/A
- Revenue
- CEPU $715,974,448.00
- BLTE N/A
- Revenue This Year
- CEPU $29.08
- BLTE N/A
- Revenue Next Year
- CEPU N/A
- BLTE N/A
- P/E Ratio
- CEPU $45.05
- BLTE N/A
- Revenue Growth
- CEPU 8.10
- BLTE N/A
- 52 Week Low
- CEPU $7.07
- BLTE $31.01
- 52 Week High
- CEPU $16.60
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- CEPU 40.14
- BLTE 58.99
- Support Level
- CEPU $11.95
- BLTE $64.10
- Resistance Level
- CEPU $12.60
- BLTE $67.40
- Average True Range (ATR)
- CEPU 0.69
- BLTE 2.33
- MACD
- CEPU 0.02
- BLTE -0.33
- Stochastic Oscillator
- CEPU 16.25
- BLTE 37.74
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a private-sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.